Literature DB >> 10101249

Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability.

L K Durrin1, R W Haile, S A Ingles, G A Coetzee.   

Abstract

Allelic variation at the 3'-end of the vitamin D receptor (VDR) gene has been associated with a 3-5-fold increased risk of developing prostate cancer and with differences in bone mineralization. This genetic diversity does not alter the VDR protein structurally, but instead may be a marker(s) of other, nearby polymorphisms that influence message stability or translation. The work reported here was instigated to identify additional VDR 3'-UTR polymorphisms that may have functional significance and to then test whether these genetic variants alter message stability. Initially, four novel, frequently occurring sequence variants were identified that associated with two common haplotypes that were described previously. These common sequence variants were not found within three message-destabilizing elements that we mapped within the 3'-UTR of the vitamin D receptor mRNA. Furthermore, the two VDR 3'-UTR haplotypes conferred an identical half-life on a heterologous beta-globin reporter gene, in an in vitro assay. We therefore conclude that common polymorphisms within the VDR 3'-UTR do not influence message stability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101249     DOI: 10.1016/s0925-4439(99)00007-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  The genetics of response to estrogen treatment.

Authors:  Bente L Langdahl
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

2.  VDR and TNFSF11 polymorphisms are associated with osteoporosis in Thai patients.

Authors:  Mananya Techapatiphandee; Nattapol Tammachote; Rachaneekorn Tammachote; Anna Wongkularb; Pattamawadee Yanatatsaneejit
Journal:  Biomed Rep       Date:  2018-08-01

3.  Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study.

Authors:  Yue Fang; Joyce B J van Meurs; Arnold d'Alesio; Mila Jhamai; Hongyan Zhao; Fernando Rivadeneira; Albert Hofman; Johannes P T van Leeuwen; Frédéric Jehan; Huibert A P Pols; André G Uitterlinden
Journal:  Am J Hum Genet       Date:  2005-09-26       Impact factor: 11.025

4.  Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in South Eastern of Iran.

Authors:  Mehrnaz Narooie-Nejad; Maryam Moossavi; Adam Torkamanzehi; Ali Moghtaderi; Saeedeh Salimi
Journal:  J Mol Neurosci       Date:  2015-02-18       Impact factor: 3.444

5.  Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.

Authors:  Nicole Denzer; Thomas Vogt; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

6.  BsmI-ApaI-TaqI TAC (BAt) Haplotype of Vitamin D Receptor Gene Is Associated with Increased Risk of Major Depressive Disorder.

Authors:  Munn-Sann Lye; Yin-Sim Tor; Yin-Yee Tey; Aishah Shahabudin; Su-Peng Loh; Normala Ibrahim; Johnson Stanslas; Rozita Rosli; King-Hwa Ling
Journal:  J Mol Neurosci       Date:  2020-10-09       Impact factor: 3.444

7.  Vitamin D receptor gene polymorphisms are linked to and associated with adult height.

Authors:  D-H Xiong; F-H Xu; P-Y Liu; H Shen; J-R Long; L Elze; R R Recker; H-W Deng
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

8.  Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.

Authors:  Glovioell W Rowland; Gary G Schwartz; Esther M John; Sue Ann Ingles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-05       Impact factor: 4.254

9.  Associations between vitamin D receptor gene polymorphisms and ankylosing spondylitis in Chinese Han population: a case-control study.

Authors:  G Cai; X Zhang; L Xin; L Wang; M Wang; X Yang; X Li; Q Xia; S Xu; C Ding; F Pan
Journal:  Osteoporos Int       Date:  2016-01-27       Impact factor: 4.507

10.  Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India.

Authors:  Neetu Israni; Ravinder Goswami; Avinash Kumar; Rajni Rani
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.